Camaisa Allan
SEC insider (Form 3/4/5 filer). CIK 0001990674. CEO and Chairman of the Board at Calidi Biotherapeutics, Inc. (CLDI). 3 reported Form 4/5 transactions since Sep 2024; latest on Dec 12, 2025. Located in SAN DIEGO,, CA.
Companies Camaisa Allan has filed insider reports for
- Calidi Biotherapeutics, Inc. (CLDI): Director, Officer, CEO and Chairman of the Board
Camaisa Allan
CIK: 0001990674
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (66.7%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CLDI
Calidi Biotherapeutics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Dec 12, 2025CLDI
Calidi Biotherapeutics, Inc.
SaleIndirect850 shares at avg. $1.46$1K - Dec 17, 2024CLDI
Calidi Biotherapeutics, Inc.
SaleDirect10K shares at avg. $1.62$16K - Sep 26, 2024CLDI
Calidi Biotherapeutics, Inc.
AwardDirect70.2K shares at avg. $1.15$81K
1-3 of 3 transactions